Stupak Turns Up the Heat on FDA - WSJ.com

Stupak Turns Up the Heat on FDA - WSJ.com: The Wall Street Journal reports in more detail about Michigan Rep. Bart Stupak’s call to overhaul the FDA. The article notes Stupak has been both personally and professionally focused on the FDA for many years, questioning the FDA’s ability to protect Americans from unsafe drugs. He is chairman of the Subcommittee on Oversight and Investigations of the House's powerful Energy and Commerce panel, which has jurisdiction over the FDA, and is at the center of an aggressive effort by congressional Democrats to spotlight what they say are problems with the Bush administration's position on consumer-safety issues. Stupak's subcommittee is probing the FDA's handling of Baxter's heparin, and holding hearings on the safety of imported food, medicines and medical devices.